DE69319346T2 - Bahandlung von tumoren mit neutrophischen faktoren und hemmern der zellproliferation - Google Patents

Bahandlung von tumoren mit neutrophischen faktoren und hemmern der zellproliferation

Info

Publication number
DE69319346T2
DE69319346T2 DE69319346T DE69319346T DE69319346T2 DE 69319346 T2 DE69319346 T2 DE 69319346T2 DE 69319346 T DE69319346 T DE 69319346T DE 69319346 T DE69319346 T DE 69319346T DE 69319346 T2 DE69319346 T2 DE 69319346T2
Authority
DE
Germany
Prior art keywords
cell proliferation
neuroblastoma cells
tumors
inhibitors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69319346T
Other languages
English (en)
Other versions
DE69319346D1 (de
Inventor
Patrizia C O Molecula Lopresti
Wojciech Poluha
Dorota Poluha
Alonzo Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Worcester Foundation for Biomedical Research
Original Assignee
Worcester Foundation for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Worcester Foundation for Biomedical Research filed Critical Worcester Foundation for Biomedical Research
Application granted granted Critical
Publication of DE69319346D1 publication Critical patent/DE69319346D1/de
Publication of DE69319346T2 publication Critical patent/DE69319346T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69319346T 1992-08-27 1993-08-26 Bahandlung von tumoren mit neutrophischen faktoren und hemmern der zellproliferation Expired - Fee Related DE69319346T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/936,923 US5387520A (en) 1992-08-27 1992-08-27 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors
PCT/US1993/008088 WO1994005315A1 (en) 1992-08-27 1993-08-26 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors

Publications (2)

Publication Number Publication Date
DE69319346D1 DE69319346D1 (de) 1998-07-30
DE69319346T2 true DE69319346T2 (de) 1999-04-01

Family

ID=25469222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69319346T Expired - Fee Related DE69319346T2 (de) 1992-08-27 1993-08-26 Bahandlung von tumoren mit neutrophischen faktoren und hemmern der zellproliferation

Country Status (10)

Country Link
US (1) US5387520A (de)
EP (1) EP0658117B1 (de)
JP (1) JPH08500836A (de)
AT (1) ATE167630T1 (de)
CA (1) CA2141935A1 (de)
DE (1) DE69319346T2 (de)
DK (1) DK0658117T3 (de)
ES (1) ES2117717T3 (de)
GR (1) GR3027661T3 (de)
WO (1) WO1994005315A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789187A (en) * 1992-08-27 1998-08-04 Worcester Foundation For Experimental Biology Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
EP0632008B1 (de) * 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentansäurederivate
JPH0856655A (ja) * 1994-08-16 1996-03-05 Frontier:Kk 細胞致死剤および細胞死抑制剤
US5648220A (en) * 1995-02-14 1997-07-15 New England Medical Center Hospitals, Inc. Methods for labeling intracytoplasmic molecules
WO2007105218A2 (en) * 2006-03-14 2007-09-20 Yeda Research And Development Co. Ltd. Composition and method for brain tumor therapy
CN114732839A (zh) * 2022-01-25 2022-07-12 长春中医药大学 人参总皂苷碳纳米点在制备抗神经母细胞瘤、抑制神经母细胞瘤细胞药物制剂领域中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE25661T1 (de) * 1982-11-10 1987-03-15 Ici Plc Aphidicolanderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
US5008252A (en) * 1987-03-20 1991-04-16 The University Of North Carolina At Chapel Hill Process for inhibiting herpes simplex virus-specified thymidine kinase

Also Published As

Publication number Publication date
EP0658117A1 (de) 1995-06-21
CA2141935A1 (en) 1994-03-17
EP0658117B1 (de) 1998-06-24
US5387520A (en) 1995-02-07
ES2117717T3 (es) 1998-08-16
DE69319346D1 (de) 1998-07-30
GR3027661T3 (en) 1998-11-30
JPH08500836A (ja) 1996-01-30
DK0658117T3 (da) 1999-02-01
ATE167630T1 (de) 1998-07-15
WO1994005315A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
TR199902194T2 (xx) +p38 protein kinaz inhibit�rleri olarak ikameli azot ihtiva eden heterosikler.
ATE281840T1 (de) Behandlung von diarrhoe
EA199900464A1 (ru) Способы и композиции для стимуляции роста невритов
ATE295889T1 (de) Gentranskription und ionisierende strahlung: methoden und zusammensetzungen
ATE188383T1 (de) Mischungen zum schutz und regenierung von geweben
FI953593A0 (fi) G-CSF-analogikoostumuksia ja menetelmiä
AU2689195A (en) Methods of inducing gene expression by ionizing radiation
ATE145337T1 (de) Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
NZ223549A (en) Macromolecular antitumour compositions containing platinum
DE69328474T2 (de) Verwendung von substituierten Adeninderivaten zur Behandlung von MultipleSklerose
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
SE8803071D0 (sv) Bakteriebehandling for att bevara hokvalitet genom att tillegga genius bacillus mikroorganismer
ATE145556T1 (de) Verwendung von interleukin-4 zur behandlung der festen tumoren
ATE167630T1 (de) Bahandlung von tumoren mit neutrophischen faktoren und hemmern der zellproliferation
ATE220923T1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE69911629D1 (de) Zusammensetzungen und deren verwendung zur hemmung von angiogenese
NO951277L (no) Desulfatohirudin med höy molekylvekt
Ikai et al. Phosphorylation of keratin polypeptides
Lenicque et al. Promotors and Inhibitors of Development during Regeneration of the Hypostome and Tentacles of Clava squamata.
NO960710D0 (no) Nye tripeptider nyttige i immun- og CNS-terapi
KR940702380A (ko) 종양 및 육종의 치료 방법(A Method for the treatment of Tumours and Sarcomas)
AU5783800A (en) Dsp-3 dual-specificity phosphatase

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee